Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.67 |
| ▸ | FAAH | O00519 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 3/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 6/20 | 0.54 |
| ▸ | PPARD | Q03181 | 6/20 | 0.54 |
| ▸ | PPARA | Q07869 | 6/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6683800 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL6972741 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL76488 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL18673409 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL2248552 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL103896 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL2485912 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL18591622 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL1649096 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL2485142 | 1.00 | HSP90AA1 (0.67) | HSP90AA1FAAHMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115692890-A | Positive electrode lithium-supplementing current collector and preparation method and application thereof | 重庆太蓝新能源有限公司 | 2023-02-03 | — | — | CN | claimed |
| EP-3794004-B1 | MOLECULAR CATALYSTS FOR SELECTIVE HYDROGENOLYSIS OF AMIDES | EASTMAN CHEM CO (US) | 2022-11-09 | — | — | EP | claimed |
| US-11111257-B2 | Molecular catalysts for selective hydrogenolysis of amides | EASTMAN CHEMICAL COMPANY (US) | 2021-09-07 | — | — | US | claimed |
| EP-3794004-A1 | MOLECULAR CATALYSTS FOR SELECTIVE HYDROGENOLYSIS OF AMIDES | Eastman Chemical Company (US) | 2021-03-24 | — | — | EP | claimed |
| CN-112105623-A | Molecular catalyst for selective hydrogenolysis of amides | 伊士曼化工公司 | 2020-12-18 | — | — | CN | claimed |
| US-20190345178-A1 | Molecular Catalysts for Selective Hydrogenolysis of Amides | EASTMAN CHEMICAL COMPANY (US) | 2019-11-14 | — | — | US | claimed |
| WO-2008059342-A2 | METHOD OF TREATING A MATERIAL, THE SO OBTAINED TREATED MATERIAL AND DEVICES CONTAINING SAID MATERIAL | ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) | 2008-05-22 | — | — | WO | claimed |
| CN-1179151-A | Lactam-containing hydroxamic acid derivatives, process for their preparation and their use as inhibitors of matrix metalloproteinases | PROCTER & GAMBLE (US) | 1998-04-15 | — | — | CN | claimed |
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12460099-B2 | Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment | THE PILOT INK CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| US-12398444-B2 | Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions | UT-BATTELLE, LLC (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250064837-A1 | TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEIR INTERMEDIATES AND USE OF INTERMEDIATES | SHANGHAITECH UNIVERSITY (CN) | 2025-02-27 | — | — | US | disclosed |
| EP-3608386-B1 | REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN | PILOT INK CO LTD (JP) | 2025-02-19 | — | — | EP | disclosed |
| US-12226424-B2 | Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates | SHANGHAITECH UNIVERSITY (CN) | 2025-02-18 | — | — | US | disclosed |
| US-5675038-A | Lithium and amine dissolving metal reduction | ALLERGAN (US) | 1997-10-07 | — | — | US | disclosed |
| EP-0587659-B1 | PHARMACEUTICAL CARRIER | BRITISH TECH GROUP (GB) | 1997-05-07 | — | — | EP | disclosed |
| US-5603958-A | COMPLEX OF STEROL AND SAPONIN | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1997-02-18 | — | — | US | disclosed |
| EP-0587659-A1 | PHARMACEUTICAL CARRIER. | ISCOVENT AB (SE) | 1994-03-23 | — | — | EP | disclosed |
| WO-1992021331-A1 | PHARMACEUTICAL CARRIER | ISCOVENT AB (SE) | 1992-12-10 | — | — | WO | disclosed |
| US-4132882-A | Process and apparatus for fixing toner with heat and a fixing agent | CANON KABUSHIKI KAISHA (JP) | 1979-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | TYR, SCO2, HBB | HSP90AA1 1824/4885FAAH 4333/4885MEN1 1317/4885 |
| US-20250064837-A1 | TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEIR INTERMEDIATES AND USE OF INTERMEDIATES | UFM1, SUMO1, SUMO2 | HSP90AA1 1006/4885FAAH 3464/4885MEN1 4056/4885 |
| US-12226424-B2 | Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates | UFM1, SUMO1, SUMO2 | HSP90AA1 933/4885FAAH 3561/4885MEN1 4125/4885 |
| US-12398444-B2 | Diglycolamide derivatives for separation and recovery of rare earth elements from aqueous solutions | GNE, GALE, ARGLU1 | HSP90AA1 2934/4885FAAH 4539/4885MEN1 2159/4885 |
| US-20190345178-A1 | Molecular Catalysts for Selective Hydrogenolysis of Amides | ADH5, ADH1A, ADH1C | HSP90AA1 2173/4885FAAH 78/4885MEN1 641/4885 |
| US-11111257-B2 | Molecular catalysts for selective hydrogenolysis of amides | ADH5, ADH1A, ADH1C | HSP90AA1 2173/4885FAAH 78/4885MEN1 641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.